Temporal arteritis in Hong Kong

International Journal of Rheumatic Diseases

Volumn 11, Issue 2, 2008, Pages 163-169

  Tam, Stanley ^a   Wong, T C ^b  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^b TSEUNG KWAN O HOSPITAL   (Hong Kong)

Author keywords

Annual incidence; HongKong; Temporal arteritis

Indexed keywords

METHYLPREDNISOLONE; PREDNISOLONE; STEROID; C REACTIVE PROTEIN;

ADULT; AGED; ANEMIA; ANOREXIA; ARTICLE; BLOOD VESSEL BIOPSY; CHINESE; CLAUDICATION; CLINICAL ARTICLE; CLINICAL FEATURE; CUSHINGOID SYNDROME; DIABETES MELLITUS; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG RESPONSE; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; FLUID RETENTION; FRAGILITY FRACTURE; HEADACHE; HONG KONG; HUMAN; INCIDENCE; JAW; LOW DRUG DOSE; MALAISE; MALE; PAIN; PEPTIC ULCER; PRIORITY JOURNAL; RECURRENT INFECTION; RETROSPECTIVE STUDY; RHEUMATIC POLYMYALGIA; SCALP; SEPSIS; SEX RATIO; SIDE EFFECT; STEROID THERAPY; TEMPORAL ARTERITIS; TEMPORAL ARTERY; TREATMENT DURATION; VISUAL IMPAIRMENT; WEIGHT REDUCTION; AGE DISTRIBUTION; JAW CLAUDICATION; MORBIDITY; MORTALITY; MUSCLE DISEASE; SCALP TENDERNESS; SKIN DISEASE;

EID: 58049166839     PISSN: 17561841     EISSN: 14798077     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2008.00352.x     Document Type: Article

References (35)

1. Baldursson O, Steinsson K, Bjornsson J, Lie JT (1994) Giant cell arteritis in Iceland: An epidemiologic and histopathologic analysis. Arthritis Rheum 37, 1007-12.
2. Bengtsson BA, Malmvall BE (1981) The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica: Incidences of different clinical presentations and eye complications. Arthritis Rheum 24, 899-904.
3. Boesen P, Sorensen SF (1987) Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county: A prospective investigation, 1982-85. Arthritis Rheum 30, 294-9.
4. Nordborg E, Bengtsson BA (1990) Epidemiology of biopsy-proven giant cell arteritis (GCA). J Intern Med 227, 233-6.
5. Franzen P, Sutinen S, VonKnorring J (1992) Giant cell arteritis and polymyalgia rheumatica in a region of Finland: An epidemiologic, clinical and pathologic study, 1984-88: J Rheumat 19, 273-6.
6. Machado EB et al. (1988) Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950-85. Arthritis Rheum 31, 745-9.
7. Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG (1995) The incidence of giant cell arteritis in Olmsted County, Minnesota: Apparent fluctuations in a cyclic pattern. Ann Intern Med 123, 192-4.
8. Salvarani C, Macchioni PL, Zizzi F (1991) Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy. Arthritis Rheum 34, 351-6.
9. Stanford RG, Berney SN (1977) Polymyalgia rheumatica and temporal arteritis in blacks: Clinical features and HLA typing. J Rheum 4, 435-42.
10. Bielroy L, Ogunkoya A, Frohman LP (1989) Temporal arteritis in blacks. Am J Med 86, 707-8.
11. Wilske KR, Healy LA, Fredrickson SR (1984) Giant cell arteritis in two Chinese patients. Arthritis Rheum 27, 120.
12. Wing YK, Kay RLC, Lai FM (1991) Giant cell arteritis in two Chinese patients. Aust N Z J Med 21, 751-2.
13. Lie JT (1992) Giant cell temporal arteritis in a Laotian Chinese. J Rheumatol 19, 1651-2.
14. Kwok AKH, Lam DSC, Liew CT (1998) Bilateral arteritic central retinal artery occlusion in a Chinese patient. Aust N Z J Ophthalmol 26, 175-6.
15. Hunder GG, Bloch DA, Michel BA, et.al. (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33, 1122-8.
16. Hunder GG, Allen GL (1973) The relationship between polymyalgia rheumatica and giant cell arteritis. Geriatrics 28, 134-42.
17. Chaudhry IA, Shamsi FA, Elzaridi E (2007) Epidemiology of giant-cell arteritis in an Arab population: A 22-year study. Br J Ophthalmol 91, 715-8.
18. Petursdottir V, Johansson H, Nordborg E, Nordborg C (1999) The epidemiology of biopsy-positive giant cell arteritis: Special reference to cyclic fluctuations. Rheumatology 38, 1208-12.
19. Nesher G, Rubinow A, Sonnenblick M (1996) Trends in the Clinical Presentation of Temporal Arteritis in Israel: Reflection of Increased Physician Awareness. Clin Rheumatol 15, 483-5.
20. Sonnenblick M, Nesher G, Friedlander Y, Rubinow A (1994) Giant cell arteritis in Jerusalem: A 12-year epidemiological study. Br J Rheumatol 33, 938-41.
21. Gonzalez-Gay MA, Miranda-Filloy JA, Lopez-Diaz MJ (2007) Giant cell arteritis in Northwestern Spain: A 25-Year Epidemiologic Study. Medicine 86, 61-8.
22. Jonasson F, Cullen JF, Elton RA (1979) Temporal arteritis: A 14-year epidemiological, clinical and prognostic study. Scott Med J 24, 111-7.
23. Smith CA, Fidler WJ, Pinals RS (1983) The epidemiology of giant cell arteritis: Report of a ten-year study in Shelby Country. Tenn Arthritis Rheum 26, 1214-9.
24. Hong Kong 1996 By-census. Hong Kong Government.
25. Hunder GG (1996) Giant cell arteritis and polymyalgia rheumatica. Textbook of Rheumatology, 5th edn. W.B. Saunders Company, Philadelphia.
26. Proven A, Gabriel S, O'Fallon M, Hunder G (1999) Long term outcome of corticosteroid therapy in a population-based study of GCA 1950-91: Arthritis Rheum 42S, 209-10.
27. Nesher G, Sonnenblick M, Friedlander Y (1994) Analysis of steroid related complications and mortality in temporal arteritis: A 15-year survey of 43 patients. J Rheumatol 21, 1283-6.
28. Proven A, Gabriel SE, Orces C, O'Fallon WM, Hunder GG (2003) Glucocorticoid therapy in giant cell arteritis: Duration and treatment outcomes. Arthritis Rheum 49, 703-8.
29. De Silva M, Hazleman BL (1986) Azathioprine in giant cell arteritis/ polymyalgia rheumatica: A double-blind study. Ann Rheum Dis 45, 136-8.
30. Spiera RF, Mitnick HJ, Kupersmith M, et al. (2001) A prospective, double blind, randomized, placebo controlled trial of Methotrexate in the treatment of giant cell arteritis (GCA). Clin Exp Rheumatol 19, 495-501.
31. Hoffman GS, Cid MC, Hellmann DB, et al. (2002) A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum 5, 1309-18.
32. Jover JA, Hernandez-Garcia C, Morado IC, Vargas E, Banares A, Fernandez-Gutierrez B (2001) Combined treatment of giant cell arteritis with methotrexate and prednisone. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 134, 106-14.
33. Mahr AD, Jover JA, Spiera RF (2007) Adjunctive methotrexate for treatment of giant cell arteritis: An individual patient data meta-analysis. Arthritis Rheum 56, 2789-97.
34. Cantini F, Niccoli L, Salvarani C, et al. (2001) Treatment of longstanding active giant cell arteritis with infliximab: Report of four cases. Arthritis Rheum 44, 2933-5. 32.
35. Hoffman GS, Cid MC, Rendt-Zagar KE, et.al. (2007) Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: A randomized trial. Ann Intern Med 146, 621-30.